NextServices

This week in the Scope Forward newsletter: ? ?? Private Equity & Healthcare Policy - Physicians facing a 6.3% Medicare pay cut, the fifth consecutive reduction, as Congress stalls reimbursement reform. - Private equity driving higher physician turnover, leading to concerns over care continuity and rising costs. - Supreme Court case could threaten free CRC screenings, potentially limiting USPSTF’s authority in preventive care guidelines. - Dr. Michael Dragutsky on the forces transforming GI, discussing private equity’s role in shaping the specialty. ?? AI & Digital Health Innovations - 10 AI use cases revolutionizing gastroenterology, from diagnostic imaging to clinical decision support. - Automatic quality control system improves adenoma detection, enhancing accuracy in colonoscopy procedures. ?? Breakthroughs in GI Care & Screening - Guardant Health’s Shield CRC test secures Medicare reimbursement, with analysts projecting $10M in revenue. - Nine best practices for IBS care, as outlined by the AGA and Rome Foundation. - Biomebank eyes U.S. expansion, bringing lab-grown gut therapies to market. ?? Physician Well-Being & Workforce Trends - 51% of gastroenterologists report burnout, according to Medscape’s 2025 Mental Health & Well-Being Report. - Women doctors don’t live longer than male doctors, challenging existing mortality trends seen in other professions. ?? Business & Market Moves - Teladoc Health has expanded its connected care program by adding partnerships with Oshi Health and Cylinder Health for comprehensive digestive health support. - Hinge Health’s IPO could reshape digital health, signaling investor confidence in virtual care models. - Medtronic CEO shares vision for the next 100 years, discussing the company’s role in shaping future healthcare innovations. #Gastroenterology #AIinHealthcare #PrivateEquity #IBS #Medicare #CRCscreening #DigitalHealth #PhysicianBurnout #ScopeForward

The future of #gastroenterology isn’t coming—it’s already here. The question isn’t whether we will shape it or be shaped by it. The real question is—will gastroenterology return to its deeper purpose, or will it drift toward irrelevance? Hippocrates famously said, "All disease begins in the gut." But what if we’ve forgotten what that truly means? What if, in the rush toward volumes, RVUs, consolidation, and automation, we’ve lost sight of the depth of GI's role in healing? Tomorrow, I’ll be at the #AGA Future Leaders Program leading a Mind-Shift Session—not just about AI, new business models, or the rise of physician-entrepreneurs, but about reclaiming the very essence of gastroenterology. The shift we are experiencing isn’t just technological—it’s a call to reimagine what GI care must mean. And that begins with #mindset. For decades, GI (and medicine itself) has evolved linearly—more procedures, more tools, more efficiency. But now, the shift is exponential. AI, robotics, precision medicine, and digital health aren’t just innovations—they are forces that will either amplify what’s broken or create an entirely new way forward. So how do we prepare? This workshop will push beyond conventional thinking and surface the real questions that matter: ?? What does the future of GI care look like in 2035? ?? What must happen TODAY to prepare? ?? What are the biggest risks and opportunities ahead? The biggest disservice we could do to GI is to preserve it as it is. Leadership isn’t about keeping things intact—it’s having the courage to build a bridge to the future even when things aren’t clearly visible. This is an important inflection point for GI and healthcare. Will you watch it happen from the sidelines, or will you lead the shift? #Mindset #Leadership #TheShift #FutureOfGI #MindShift #ExponentialChange #AGAFutureLeaders Thank you American Gastroenterological Association (AGA) for having the courage to lead GI to the future. Lubin Arevalo Veroushka Ballester Vargas Victor Chedid @Ryan Fawley, @Melissa Hershman, Sigh Pichamol Jirapinyo, MD, MPH, DABOM, FASGE, FACG, @Babu Pappu Mohan, Carolyn Newberry, @Long H. Nguyen, Neha Nigam, Andrew Ofosu MD MPH, Arpan Patel MD PhD, @Ronak Vashi Patel, @Mimi Chang Tan, @Louise Wang, @Alex Zhornitskiy

This week in the Scope Forward newsletter: ? ?? Clinical Practice & Guidelines - Optimizing bowel prep for colonoscopy—New consensus guidelines from the US Multi-Society Task Force emphasize best practices for improving colonoscopy quality - Surgical vs. endoscopic removal of large colon polyps—EMR and ESD techniques reduce need for surgery ?? Business Moves & Industry Trends - Walgreens goes private in $10B deal with Sycamore Partners, ending its century-long public company status - The high cost of GI physician turnover—Significant onboarding and replacement expenses outlined in AMN Healthcare’s latest report - Supergut raises capital, hires new CEO, positioning itself as a leader in GLP-1 linked digestive health products - Oshi Health joins Accolade's Trusted Partner Ecosystem, expanding access to virtual GI care ?? Artificial Intelligence - AI’s present and future in GI care—Dr. Aasma Shaukat shares insights on how AI is transforming gastroenterology - Are doctors a dying breed? AI's growing role raises critical questions about the future of the profession ?? Emerging Science & Therapies - Vaccine to prevent colorectal cancer? Dr. Olivera Finn leads groundbreaking research on MUC1-targeted immunotherapy - New treatments for ulcerative colitis—Two global studies highlight promising breakthroughs - Colorectal cancer screening remains a hard sell, but Inspira Health’s Dr. Senatore emphasizes that any screening method is critical ?? Tech & Telehealth - Telehealth reduces unnecessary GI-related ER visits, with a 90% diversion success rate in a pilot study by MNGI Digestive Health and WovenX Health - 6 HIMSS announcements not to miss, including major health tech partnerships and product launches ?? Pop Culture & Healthcare - The Pitt becomes a doctor favorite, praised for its realistic depiction of hospital life #digestivehealth #gastroenterology #AIinHealthcare #GLP1 #coloncancer #IBD #telehealth #GIinnovation #ScopeForward

Our Shield? blood test has received Advanced Diagnostic Laboratory Test (ADLT) status from the Centers for Medicare & Medicaid Services, showing the unique value of the Shield test for CRC screening. This is another step forward in improving colorectal cancer screening rates and expanding patient access. “We’ve already seen strong adoption by providers with Medicare-covered patient populations. This designation from CMS and a more favorable Medicare rate will help us bring the innovation of Shield to more patients coast-to-coast by accelerating our investments in building our commercial infrastructure," added our co-CEO AmirAli Talasaz.

AI isn't just hype — it's about to transform gastroenterology. From AI-assisted colonoscopies to predictive analytics that catch diseases before they strike, the future of GI is already here. But are we ready? ?? Discover 10 powerful AI use cases that could redefine patient care, diagnostics, and practice management in gastroenterology. ?? Read the full article: https://lnkd.in/dGvBCmXz #Gastroenterology #ArtificialIntelligence #HealthTech #GIInnovation #MedicalAI

News Alert: Coverage of updated consensus recommendations on optimizing bowel prep for #colonoscopy via Healio #Gastroenterology: "US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’" -- the MSTFCRC includes the American College of Gastroenterology, American Gastroenterological Association (AGA) and American Society for Gastrointestinal Endoscopy (ASGE). Thanks Robert Stott for thoughtful coverage! #ColorectalCancerAwarenessMonth https://lnkd.in/e9sqmtGD

?? The Future of GI Is Here—Are You Ready? In the latest episode of The Scope Forward Show, Dr. Michael Dragutsky (Chairman of One GI?) dives deep into the forces transforming gastroenterology: ?? Private Equity & Physician Leverage ?? GI Physician Shortage & the Rise of APPs ?? AI, Robotics & the Next Era of Care But here’s the twist—amidst all the tech talk, Dr. Dragutsky insists that mindfulness, empathy, and the human touch remain irreplaceable. ?? Don’t miss this thought-provoking conversation on how GI is evolving—and what it means for the future. Watch the interview: https://lnkd.in/dXvRkGQw Listen to the podcast: https://lnkd.in/da9zXbbF #Gastroenterology #GI #privateequity #artificialintelligence #AI #precisionmedicine #digitalhealth #ScopeForward

This week in the Scope Forward newsletter: ?? Industry Growth & Consolidation - Can value-based care support independent practices? Experts explore whether value-based models can counteract the trend of healthcare consolidation - Gastro Health unveils bold expansion strategy, with new leadership focused on strengthening its market position ?? Breakthroughs in GI Diagnostics & Treatment - Machine learning identifies gut biomarkers for IBD, improving diagnostic accuracy for Crohn’s disease and ulcerative colitis - Blood-based microRNA panel shows promise for esophageal cancer detection, offering a less invasive screening alternative - Capsule endoscopy market set to grow, as AI-powered technology advances non-invasive diagnostics - The world's first 'poop pill' enters trials, using fecal microbiota transplantation to enhance chemotherapy response in pancreatic cancer - GLP-1 receptor agonists linked to poor colonoscopy prep, doubling the risk of inadequate bowel cleansing ?? Regulatory & Financial Challenges - Providers wasted nearly $18B overturning claim denials, underscoring inefficiencies in the reimbursement system - Guardant Health sues Natera, alleging misappropriation of cancer-testing trade secrets ?? AI & the Future of GI Care - DeepSeek poised to disrupt medicine, enabling innovators to develop next-generation AI medical tools - The future of IBD care, as experts review recent breakthroughs and future therapeutic directions - AI may soon prescribe medicine, with a proposed bill allowing FDA-approved AI prescribing under state authorization ?? CRC Prevention & Liver Disease Research - Colorectal cancer risk linked to steatotic liver disease, highlighting the need for targeted screening in high-risk patients ? #gastroenterology #AIinHealthcare #CRCscreening #healthcarepolicy #IBDcare #medicalinnovation #ScopeForward

Novo Nordisk A/S, the maker of Ozempic, just revealed that they began using the generative AI Claude 3 Sonnet to draft clinical study reports spanning hundreds of pages.? This has led to significantly shortening the drafting time from about 15 weeks to less than 10 minutes! And how much does the company spend on this? ???????? ???????? ?????? ???????????? ???????????? ???? ?? ???????????? ????????????! In the extremely regulated industry, this is a huge step forward and I especially liked their strategy: "???? ???? ???????????????? ??????? ????????-?????????????? ??/?? ????? ?????????????? ?? ???????????? ??????????? ???? ???????????? ???? ?????????? ??????????: ??????????????????-?????????????????? ???????????????????? (??????).? ?????? ??????????????, ??????? ???????????? ?????????????????? ?? ???????????????? ???????????????????? ???? ?????????????? ??????? ?? ????????? ???????????? ???????????? ????????, ????? ????????? ?????????? ???????????????? ???????????? ???? ?????????? ??????? ?????????????????????? ???? ?????? ???????????? ?????????????????? ?????????? ?????????????? ????????????." Excellent! Humans making AI better. And also for the naysayers: "The company stated that it does not plan to cut any writing staff for now, but it intends to reduce new hiring and allocate the saved resources to recruitment in other departments." Source: https://lnkd.in/eiFtdjJT